相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of MYC in regulation of tumor cell metabolism
Therese Wahlstrom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Tumoral reprogramming: Plasticity takes a walk on the wild side
Elena Campos-Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy
Carolina Vicente-Duenas et al.
SEMINARS IN CANCER BIOLOGY (2015)
Metabolic Regulation of Redox Status in Stem Cells
Ester Perales-Clemente et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Robert J. Vanner et al.
CANCER CELL (2014)
Sox2: Masterminding the Root of Cancer
Wai Leong Tam et al.
CANCER CELL (2014)
Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
Lindsay E. Wu et al.
CANCER CELL (2014)
Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models
Pei Zhu et al.
CANCER PREVENTION RESEARCH (2014)
Gerometabolites The pseudohypoxic aging side of cancer oncometabolites
Javier A. Menendez et al.
CELL CYCLE (2014)
Reprogramming the epigenetic landscapes of patient- derived cancer genomes
Javier A. Menendez et al.
CELL CYCLE (2014)
Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway
P-P Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Dietary and Metabolic Control of Stem Cell Function in Physiology and Cancer
Maria M. Mihaylova et al.
CELL STEM CELL (2014)
Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
Darrell R. Borger et al.
CLINICAL CANCER RESEARCH (2014)
Dedifferentiation and reprogramming: origins of cancer stem cells
Dinorah Friedmann-Morvinski et al.
EMBO REPORTS (2014)
Mitochondrial Function in Pluripotent Stem Cells and Cellular Reprogramming
Raul Bukowiecki et al.
GERONTOLOGY (2014)
Cancer Stem Cell Theory and the Warburg Effect, Two Sides of the Same Coin?
Nicola Pacini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Atsushi Terunuma et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Soufiane Boumahdi et al.
NATURE (2014)
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Supriya K. Saha et al.
NATURE (2014)
Metabolic requirements for the maintenance of self-renewing stem cells
Keisuke Ito et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Rare insights into cancer biology
J. Adam et al.
ONCOGENE (2014)
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors
M. Nishi et al.
ONCOGENE (2014)
Mathematical approaches to modeling development and reprogramming
Rob Morris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
Andreas Janzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
D. Ciavardelli et al.
CELL DEATH & DISEASE (2014)
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Paula Lopez-Serra et al.
NATURE COMMUNICATIONS (2014)
The nutritional phenome of EMT-induced cancer stem-like cells
Elisabet Cuyas et al.
ONCOTARGET (2014)
A stochastic model dissects cell states in biological transition processes
Jonathan W. Armond et al.
SCIENTIFIC REPORTS (2014)
Cancer: pathological nuclear reprogramming?
Colin R. Goding et al.
NATURE REVIEWS CANCER (2014)
Defects in mitochondrial metabolism and cancer
Edoardo Gaude et al.
CANCER & METABOLISM (2014)
Nichotherapy for stem cells: There goes the neighborhood
Jean-Pierre Levesque et al.
BIOESSAYS (2013)
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Chenfang Dong et al.
CANCER CELL (2013)
Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame?
Evelyn Fessler et al.
CANCER LETTERS (2013)
Statistical Mechanics of Pluripotency
Ben D. MacArthur et al.
CELL (2013)
Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers
Jian Shu et al.
CELL (2013)
Metformin selectively affects human glioblastoma tumor-initiating cell viability A role for metformin-induced inhibition of Akt
Roberto Wuerth et al.
CELL CYCLE (2013)
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil A new family of gerosuppressant agents
Javier A. Menendez et al.
CELL CYCLE (2013)
The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
Javier A. Menendez et al.
CELL CYCLE (2013)
Metabolome and metaboproteome remodeling in nuclear reprogramming
Clifford D. L. Folmes et al.
CELL CYCLE (2013)
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
Bruna Corominas-Faja et al.
CELL CYCLE (2013)
The mitochondrial H+-ATP synthase and the lipogenic switch New core components of metabolic reprogramming in induced pluripotent stem (iPS) cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2013)
Metabolic Regulation by p53 Family Members
Celia R. Berkers et al.
CELL METABOLISM (2013)
Mitochondrial Regulation in Pluripotent Stem Cells
Xiuling Xu et al.
CELL METABOLISM (2013)
Transient Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important Early Step in Reprogramming to Pluripotency
Shuo Wang et al.
CELL STEM CELL (2013)
Chemical Approaches to Stem Cell Biology and Therapeutics
Wenlin Li et al.
CELL STEM CELL (2013)
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets
Daniel Krell et al.
FUTURE ONCOLOGY (2013)
LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7
Blair B. Madison et al.
GENES & DEVELOPMENT (2013)
Exploiting tumor metabolism: challenges for clinical translation
Matthew G. Vander Heiden
JOURNAL OF CLINICAL INVESTIGATION (2013)
Potential applications for biguanides in oncology
Michael Pollak
JOURNAL OF CLINICAL INVESTIGATION (2013)
Oncometabolites: linking altered metabolism with cancer
Ming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Proto-oncometabolite Fumarate Binds Glutathione to Amplify ROS-Dependent Signaling
Lucas B. Sullivan et al.
MOLECULAR CELL (2013)
Deterministic direct reprogramming of somatic cells to pluripotency
Yoach Rais et al.
NATURE (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Heterogeneity of tumor-induced gene expression changes in the human metabolic network
Jie Hu et al.
NATURE BIOTECHNOLOGY (2013)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells
Enza Lonardo et al.
PLOS ONE (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Epigenetic Reprogramming in Cancer
Mario L. Suva et al.
SCIENCE (2013)
Quantitative imaging of subcellular metabolism with stable isotopes and multi-isotope imaging mass spectrometry
Matthew L. Steinhauser et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2013)
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
Altaf Mohammed et al.
TRANSLATIONAL ONCOLOGY (2013)
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
Rob A. Cairns et al.
CANCER DISCOVERY (2013)
Expression of the pluripotency transcription factor OCT4 in the normal and aberrant mammary gland
Foteini Hassiotou et al.
FRONTIERS IN ONCOLOGY (2013)
Serine, glycine and one-carbon units: cancer metabolism in full circle
Jason W. Locasale
NATURE REVIEWS CANCER (2013)
Mitochondrial fusion by pharmacological manipulation impedes somatic cell reprogramming to pluripotency: New insight into the role of mitophagy in cell stemness
Alejandro Vazquez-Martin et al.
AGING-US (2012)
Energy metabolism plasticity enables stemness programs
Clifford D. L. Folmes et al.
EVOLVING CHALLENGES IN PROMOTING CARDIOVASCULAR HEALTH (2012)
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Federica Sotgia et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
Metformin and Cancer Stem Cells: Old Drug, New Targets
Filip Bednar et al.
CANCER PREVENTION RESEARCH (2012)
Connecting Threads: Epigenetics and Metabolism
Sayako Katada et al.
CELL (2012)
Two-compartment tumor metabolism Autophagy in the tumor microenvironment, and oxidative mitochondrial metabolism (OXPHOS) in cancer cells
Ahmed F. Salem et al.
CELL CYCLE (2012)
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells
Alejandro Vazquez-Martin et al.
CELL CYCLE (2012)
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Mariia O. Yuneva et al.
CELL METABOLISM (2012)
The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming
Athanasia D. Panopoulos et al.
CELL RESEARCH (2012)
Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal
Jin Zhang et al.
CELL STEM CELL (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
Metabolic Plasticity in Stem Cell Homeostasis and Differentiation
Clifford D. L. Folmes et al.
CELL STEM CELL (2012)
Aging and reprogramming: a two-way street
Salah Mahmoudi et al.
CURRENT OPINION IN CELL BIOLOGY (2012)
Sirtuin Catalysis and Regulation
Jessica L. Feldman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate
Victoria A. Rafalski et al.
JOURNAL OF CELL SCIENCE (2012)
Small molecules, big roles - the chemical manipulation of stem cell fate and somatic cell reprogramming
Yu Zhang et al.
JOURNAL OF CELL SCIENCE (2012)
Co-expression of Oct-4 and Nestin in human breast cancers
Caigang Liu et al.
MOLECULAR BIOLOGY REPORTS (2012)
The developing cancer stem-cell model: clinical challenges and opportunities
Louis Vermeulen et al.
LANCET ONCOLOGY (2012)
The potential role of nutritional genomics tools in validating high health foods for cancer control: Broccoli as example
Lynnette R. Ferguson et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism
Matthew L. Steinhauser et al.
NATURE (2012)
Sox2 expression in breast tumours and activation in breast cancer stem cells
O. Leis et al.
ONCOGENE (2012)
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state
Christos Polytarchou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hallmarks of cancer: of all cancer cells, all the time?
Sebastien L. Floor et al.
TRENDS IN MOLECULAR MEDICINE (2012)
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+human breast cancer xenografts
Silvia Cufi et al.
ONCOTARGET (2012)
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Chang W. Song et al.
SCIENTIFIC REPORTS (2012)
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
Alejandro Vazquez-Martin et al.
SCIENTIFIC REPORTS (2012)
Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
Atsushi Sato et al.
STEM CELLS TRANSLATIONAL MEDICINE (2012)
The emerging role of fumarate as an oncometabolite
Ming Yang et al.
FRONTIERS IN ONCOLOGY (2012)
p53 and metabolism Old player in a new game
Nirmalya Sen et al.
TRANSCRIPTION-AUSTIN (2012)
Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells
Taotao Chen et al.
AGING CELL (2011)
Clinical Implications of Stem Cell Gene Oct-4 Expression in Breast Cancer
Cai-gang Liu et al.
ANNALS OF SURGERY (2011)
Energy metabolism in nuclear reprogramming
Clifford D. L. Folmes et al.
BIOMARKERS IN MEDICINE (2011)
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Claudia Lengerke et al.
BMC CANCER (2011)
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
Alejandro Vazquez-Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2011)
mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency A roadmap from energy metabolism to stem cell renewal and aging
Javier A. Menendez et al.
CELL CYCLE (2011)
Ketones and lactate increase cancer cell stemness, driving recurrence, metastasis and poor clinical outcome in breast cancer
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2011)
Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
Clifford D. L. Folmes et al.
CELL METABOLISM (2011)
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
Alejandro Vazquez-Martin et al.
DRUG RESISTANCE UPDATES (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
Mammalian Sirtuins and Energy Metabolism
Xiaoling Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Inborn and acquired metabolic defects in cancer
Christian Frezza et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Metabolic regulation by p53
Oliver D. K. Maddocks et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds
Yanyan Li et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Nirmalya Sen et al.
MOLECULAR CELL (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme
Amparo Wolf et al.
NEUROBIOLOGY OF DISEASE (2011)
Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations
S. Floor et al.
ONCOGENE (2011)
Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
Mingquan Chen et al.
PLOS ONE (2011)
Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
Ji-Won Jung et al.
PLOS ONE (2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
Dimitrios Iliopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Transdifferentiation of glioblastoma cells into vascular endothelial cells
Yasushi Soda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
Glutamine Synthetase Is a Genetic Determinant of Cell Type-Specific Glutamine Independence in Breast Epithelia
Hsiu-Ni Kung et al.
PLOS GENETICS (2011)
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor
Adriana S. Beltran et al.
BREAST CANCER RESEARCH (2011)
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
Elsa Quintana et al.
CANCER CELL (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Chi V. Dang
CANCER RESEARCH (2010)
Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells
Xiaojun Yang et al.
CANCER RESEARCH (2010)
CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor-Negative Breast Cancer
Matthew J. Meyer et al.
CANCER RESEARCH (2010)
Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis
C. Maenhaut et al.
CARCINOGENESIS (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
Jacob H. Hanna et al.
CELL (2010)
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT) From cancer stem cells to aging-associated fibrosis
Silvia Cufi et al.
CELL CYCLE (2010)
Ketones and lactate fuel tumor growth and metastasis Evidence that epithelial cancer cells use oxidative mitochondrial metabolism
Gloria Bonuccelli et al.
CELL CYCLE (2010)
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
Alejandro Vazquez-Martin et al.
CELL CYCLE (2010)
Metformin and cancer Doses, mechanisms and the dandelion and hormetic phenomena
Begona Martin-Castillo et al.
CELL CYCLE (2010)
Histone Methyl Transferases and Demethylases; Can They Link Metabolism and Transcription?
Raffaele Teperino et al.
CELL METABOLISM (2010)
Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
A. Vazquez-Martin et al.
CURRENT MOLECULAR MEDICINE (2010)
Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells
Alessandro Prigione et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Identification of MicroRNAs Regulating Reprogramming Factor LIN28 in Embryonic Stem Cells and Cancer Cells
Xiaomin Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
p53 connects tumorigenesis and reprogramming to pluripotency
Natalia Tapia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells
Rachel Sarig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Energetics, epigenetics, mitochondrial genetics
Douglas C. Wallace et al.
MITOCHONDRION (2010)
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
X. Liu et al.
ONCOGENE (2010)
Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer
S. Peng et al.
ONCOGENE (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells
Alessandro Prigione et al.
STEM CELLS (2010)
Embryonic stem cell markers expression in cancers
Matthieu Schoenhals et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Reprogramming cell fates: reconciling rarity with robustness
Sui Huang
BIOESSAYS (2009)
Acting Locally and Globally: Myc's Ever-Expanding Roles on Chromatin
Natalia V. Varlakhanova et al.
CANCER RESEARCH (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
Stem Cell States, Fates, and the Rules of Attraction
Tariq Enver et al.
CELL STEM CELL (2009)
Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures
Mark H. Chin et al.
CELL STEM CELL (2009)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Metabolic defects provide a spark for the epigenetic switch in cancer
Michael J. Hitchler et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Tumor suppressors and cell metabolism: a recipe for cancer growth
Russell G. Jones et al.
GENES & DEVELOPMENT (2009)
The role of poly(ADP-ribosyl)ation in epigenetic events
Delphine Quenet et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Elite and stochastic models for induced pluripotent stem cell generation
Shinya Yamanaka
NATURE (2009)
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Teruhisa Kawamura et al.
NATURE (2009)
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Rosa M. Marion et al.
NATURE (2009)
Direct cell reprogramming is a stochastic process amenable to acceleration
Jacob Hanna et al.
NATURE (2009)
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
Hyenjong Hong et al.
NATURE (2009)
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Jochen Utikal et al.
NATURE (2009)
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Han Li et al.
NATURE (2009)
Systems biology of stem cell fate and cellular reprogramming
Ben D. MacArthur et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
Chunaram Choudhary et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
Epigenetic signatures in stem cells and cancer stem cells
Hector Hernandez-Vargas et al.
EPIGENOMICS (2009)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression
Samuel Godar et al.
CELL (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Pierre Sonveaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The ground state of embryonic stem cell self-renewal
Qi-Long Ying et al.
NATURE (2008)
P53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Keiko Kawauchi et al.
NATURE CELL BIOLOGY (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
NAD+ metabolism in health and disease
Peter Belenky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey
Sung Chan Kim et al.
MOLECULAR CELL (2006)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Poly(ADP-ribose):: novel functions for an old molecule
Valerie Schreiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Normal and leukemic hematopoiesis:: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?
E Passegué et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Glucose metabolism in cancer - Evidence that demethylation events play a role in activating type II hexokinase gene expression
A Goel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
分享论文
